Recent research indicates that retatrutide, a innovative medication, could significantly impact the treatment of excess weight . Unlike many current weight reduction therapies , retatrutide functions as both a GLP-1 agonist and a GIP agonist, affecting several hormones involved in cravings balance and blood sugar optimization. Initial clinical tri